Similar to solid tumors, N-cadherin expression is increased in many types of hematologic malignancies as well as in BM niche-primed leukemia cells [114,115,116], and N-cadherin-mediated adhesion supports the resistance of leukemia cells to chemotherapeutic agents [117]. This evidence concerns the gene CDH2 and hematologic disorder.